GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
The DOI matches its Crossref record; 52 of the 56 references it cites were found in a registry or an index.
Abstract
Obesity and diabetes are characterized by increased inflammation reflecting disordered control of innate immunity. We reveal a local intestinal intraepithelial lymphocyte (IEL)-GLP-1 receptor (GLP-1R) signaling network that controls mucosal immune responses. Glp1r expression was enriched in intestinal IEL preparations and copurified with markers of Tαβ and Tγδ IELs, the two main subsets of intestinal IELs. Exendin-4 increased cAMP accumulation in purified IELs and reduced the production of cytokines from activated IELs but not from splenocytes ex vivo. These actions were mimicked by forskolin, absent in IELs from Glp1r−/− mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action. Furthermore, Glp1r−/− mice exhibited dysregulated intestinal gene expression, an abnormal representation of microbial species in feces, and enhanced sensitivity to intestinal injury following administration of dextran sodium sulfate. Bone marrow transplantation using wild-type C57BL/6 donors normalized expression of multiple genes regulating immune function and epithelial integrity in Glp1r−/− recipient mice, whereas acute exendin-4 administration robustly induced the expression of genes encoding cytokines and chemokines in normal and injured intestine. Taken together, these findings define a local enteroendocrine-IEL axis linking energy availability, host microbial responses, and mucosal integrity to the control of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the inflammatory environment, the M1 to M2 shift promoted by GLP-1 is crucial for reducing the expression of inflammatory factors such as IL-6, TNF-α, and iNOS.8,15,328”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [328]
In the citing paper
“Thymus, bone marrow, spleen, mesenteric lymph nodes, brachial/axillary lymph nodes, inguinal lymph nodes, and PBMCs express low levels of Glp1r (29, 33, 34).”
From Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits (2025) · cites this paper as [33]
In the citing paper
“In the small intestine, intraepithelial lymphocytes (IELs) express high levels of Glp1r, triggering cAMP response upon activation by exendin-4 (33).”
From Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits (2025) · cites this paper as [33]
In the citing paper
“Glp1r–/– mice exhibited exacerbated intestinal inflammation in a dextran sulfate sodium–induced model of colitis (33).”
From Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits (2025) · cites this paper as [33]
In the citing paper
“Notably, GLP-1R expression in gut IELs is significantly lower in the colon than in the small intestine (33), suggesting that other cell types, such as enteric neurons (82), may contribute to the antiinflammatory actions of GLP-1 medicines in the colon.”
From Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits (2025) · cites this paper as [33]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialDrucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · cited 1×
“GLP-1 controls gut motility and food intake and stimulates insulin while simultaneously inhibiting glucagon secretion (4,5).”
BackgroundSelf-citationCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“Indeed, modulation (both gain and loss) of GLP-2R signaling robustly modifies gut barrier function and the extent of inflammation in murine models of diabetes characterized by gut injury and endotoxemia (46).”
BackgroundIntegrative analysis of environmental sequences using MEGAN4
Huson, D. H., Mitra, S., Ruscheweyh, H.-J., Weber, N., & Schuster, S. C. (2011) · Genome Research · doi:10.1101/gr.120618.111 · Cited by 1,541 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 9×
“Indeed, transient blockade of GLP-1 receptor (GLP-1R) signaling reduces insulin, increases glucagon, and impairs glucose tolerance in multiple species (4).”
BackgroundInfluentialSelf-citationEllingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922 · cited 3×
“GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.”
BackgroundSelf-citationPyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialThe light and dark sides of intestinal intraepithelial lymphocytes
Cheroutre, H., Lambolez, F., & Mucida, D. (2011) · Nature Reviews Immunology · doi:10.1038/nri3007 · Cited by 693 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialGlucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654 · cited 1×
“Proglucagon-producing L cells are among the most intensively studied enteroendocrine cells predominantly localized to the distal small bowel and colon (3).”
BackgroundInsights into the role of the microbiome in obesity and type 2 diabetes
Hartstra, A. V., Bouter, K. E. C., Bäckhed, F., & Nieuwdorp, M. (2015) · Diabetes Care · doi:10.2337/dc14-0769 · Cited by 641 · cited 4×
“Remarkably, highly significant differences in the relative abundance of Gammaproteobacteria, Bacteroidetes, Firmicutes, and Actinobacteria were detected.”
BackgroundInfluentialTissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614 · cited 1×
“Enteroendocrinederived hormones also act as classical hormones controlling metabolism through regulation of energy intake, digestion, absorption, and the disposal and storage of digested nutrients (1).”
BackgroundSelf-citationBacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells
Chimerel, C., Emery, E., Summers, D. K., Keyser, U., Gribble, F. M., & Reimann, F. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.032 · Cited by 548 · cited 1×
“Germ-free mice exhibit increased levels of circulating GLP-1 and enhanced proglucagon expression in the murine brainstem (47) and distal gut (48), whereas microbial metabolites such as indole directly activate GLP-1 secretion from L cells (49).”
BackgroundProtection of the intestinal mucosa by intraepithelial γδ T cells
Chen, Y., Chou, K., Fuchs, E., Havran, W. L., & Boismenu, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212290499 · Cited by 480
Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472
Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
Wichmann, A., Allahyar, A., Greiner, T. U., Plovier, H., Lundén, G. Ö., Larsson, T., Drucker, D. J., Delzenne, N. M., Cani, P. D., & Bäckhed, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.012 · Cited by 380
Self-citationCampos, R. V. (1994) · Endocrinology · doi:10.1210/en.134.5.2156 · Cited by 353 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialSelf-citationPanjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., Streutker, C., Holland, D., Cao, X., Baggio, L. L., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1937 · Cited by 346 · cited 13×
“The Glp1r Is Expressed in Murine Intestinal IELs Recent studies highlighted limitations of commercially available antisera for detection of immunoreactive GLP-1R expression (16,22).”
BackgroundMethodInfluentialSelf-citationPhysiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
Drucker, D. J., & Yusta, B. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170317 · Cited by 342 · cited 1×
“In contrast, GLP-2 acts more locally within the gut to increase nutrient absorption and maintain the integrity of the gut epithelium (6).”
BackgroundSelf-citationHansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialSelf-citationExtrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290 · cited 1×
“Of note, Glp1r mice exhibit resistance to diet-induced obesity (51), increased relative abundance of Bacteroidetes, and reduced abundance of Firmicutes in their microbiota, whereas obese mice show a decrease in Bacteroidetes and an increase in Firmicutes (52).”
BackgroundSelf-citationEnteroendocrine cells express functional Toll-like receptors
Bogunovic, M., Davé, S. H., Tilstra, J. S., Chang, D. T. W., Harpaz, N., Xiong, H., Mayer, L. F., & Plevy, S. E. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00249.2006 · Cited by 230 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialKahles, F., Meyer, C., Möllmann, J., Diebold, S., Findeisen, H. M., Lebherz, C., Trautwein, C., Koch, A., Tacke, F., Marx, N., et al. (2014) · Diabetes · doi:10.2337/db14-0100 · Cited by 212 · cited 8×
“GLP-1 secretion is also induced by bacterial endotoxin, enabling lipopolysaccharide (LPS)-mediated glucoregulation through the GLP-1R (9,10).”
BackgroundMethodInfluentialSchéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., & Jansson, J.-O. (2013) · Endocrinology · doi:10.1210/en.2012-2151 · Cited by 209 · cited 1×
“Germ-free mice exhibit increased levels of circulating GLP-1 and enhanced proglucagon expression in the murine brainstem (47) and distal gut (48), whereas microbial metabolites such as indole directly activate GLP-1 secretion from L cells (49).”
BackgroundLefrançois, L., & Lycke, N. (1996) · Current Protocols in Immunology · doi:10.1002/0471142735.im0319s17 · Cited by 207 · cited 12×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialInnate Immune Receptors: Key Regulators of Metabolic Disease Progression
Jin, C., Henao-Mejia, J., & Flavell, R. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.011 · Cited by 189 · cited 12×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialBoushey, R. P., Yusta, B., & Drucker, D. J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e937 · Cited by 179
Self-citationHuman [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Drucker, D. J., Yusta, B., Boushey, R. P., DeForest, L., & Brubaker, P. L. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.1.g79 · Cited by 176
Self-citationHadjiyanni, I., Siminovitch, K. A., Danska, J. S., & Drucker, D. J. (2010) · Diabetologia · doi:10.1007/s00125-009-1643-x · Cited by 166 · cited 12×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialSelf-citationNguyen, A. T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D. J., Lagrost, L., & Grober, J. (2014) · Diabetes · doi:10.2337/db13-0903 · Cited by 161
Self-citationThe Glucagon-Like Peptide-1 Receptor—or Not?
Pyke, C., & Knudsen, L. B. (2013) · Endocrinology · doi:10.1210/en.2012-2124 · Cited by 154
Boushey, R. P., Yusta, B., & Drucker, D. J. (2001) · PubMed · Cited by 150
Self-citationWang, H., Steeds, J., Motomura, Y., Deng, Y., Verma-Gandhu, M., El-Sharkawy, R. T., McLaughlin, J. T., Grencis, R. K., & Khan, W. I. (2007) · Gut · doi:10.1136/gut.2006.103226 · Cited by 122 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodResultInfluentialIs glucagon-like peptide 1 an incretin hormone?
Nauck, M. A. (1999) · Diabetologia · doi:10.1007/s001250051165 · Cited by 112 · cited 3×
“GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.”
BackgroundCirculating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
Xiao, Q., Boushey, R. P., Cino, M., Drucker, D. J., & Brubaker, P. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r1057 · Cited by 111 · cited 1×
“Plasma levels of some gut hormones, including the glucagon-like peptides, also increase rapidly in the presence of intestinal injury or mucosal inflammation (2).”
BackgroundSelf-citationAssa, A., Vong, L., Pinnell, L. J., Rautava, J., Avitzur, N., Johnson-Henry, K. C., & Sherman, P. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000282 · Cited by 85 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialSelf-citationLee, S.-J., Lee, J., Li, K. K., Holland, D., Maughan, H., Guttman, D. S., Yusta, B., & Drucker, D. J. (2012) · Endocrinology · doi:10.1210/en.2011-1954 · Cited by 75 · cited 1×
“Conversely, disruption of GLP-2R signaling was associated with increased bacterial colonization of the small bowel, reduced bactericidal activity, impaired Paneth cell responses (43), and enhanced susceptibility to gut injury and inflammation (43).”
BackgroundSelf-citationGlucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
Drucker, D. J., & Rosen, C. F. (2011) · Diabetologia · doi:10.1007/s00125-011-2297-z · Cited by 66 · cited 9×
“Indeed, pharmacological administration of GLP-1R agonists has exerted anti-inflammatory actions in multiple studies through incompletely understood mechanisms (39).”
BackgroundMethodInfluentialSelf-citationHadjiyanni, I., Li, K. K., & Drucker, D. J. (2008) · Endocrinology · doi:10.1210/en.2008-1228 · Cited by 65 · cited 1×
“The anti-inflammatory actions of GLP-2 are indirect, mediated through reduction of gut permeability (44,45).”
BackgroundSelf-citationSelleri, S., Palazzo, M., Deola, S., Wang, E., Balsari, A., Marincola, F. M., & Rumio, C. (2008) · International Immunology · doi:10.1093/intimm/dxn055 · Cited by 64
Glucagon-Like Peptide-2 Receptor Modulates Islet Adaptation to Metabolic Stress in the ob/ob Mouse
Bahrami, J., Longuet, C., Baggio, L. L., Li, K., & Drucker, D. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.006 · Cited by 63 · cited 1×
“The anti-inflammatory actions of GLP-2 are indirect, mediated through reduction of gut permeability (44,45).”
BackgroundSelf-citationNutrient sensing and metabolic stress pathways in innate immunity
Tsalikis, J., Croitoru, D. O., Philpott, D. J., & Girardin, S. E. (2013) · Cellular Microbiology · doi:10.1111/cmi.12165 · Cited by 60
Schmidtler, J., Dehne, K., Allescher, H. D., Schusdziarra, V., Classen, M., Holst, J. J., Polack, A., & Schepp, W. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.267.3.g423 · Cited by 54
Antagonism of central glucagon-like peptide-1 receptors enhances lipopolysaccharide-induced fever
Rinaman, L., & Comer, J. E. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00227-7 · Cited by 41 · cited 12×
“GLP-1 secretion is also induced by bacterial endotoxin, enabling lipopolysaccharide (LPS)-mediated glucoregulation through the GLP-1R (9,10).”
BackgroundMethodInfluentialKedees, M. H., Guz, Y., Grigoryan, M., & Teitelman, G. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.022 · Cited by 40 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialEffects of Intraepithelial Lymphocyte-Derived Cytokines on Intestinal Mucosal Barrier Function
Qiu, Y., & Yang, H. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0162 · Cited by 40
Leung, F. W., Miller, J. C., Reedy, T. J., & Guth, P. H. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540045 · Cited by 30 · cited 11×
“Animals were euthanized on day 8, and for each mouse, a disease activity index score was calculated (14).”
BackgroundMethodInfluentialPais, R., Zietek, T., Hauner, H., Daniel, H., & Skurk, T. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00329.2013 · Cited by 26 · cited 8×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialFrontline T cells: γδ T cells and intraepithelial lymphocytes
Kronenberg, M., & Havran, W. L. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00489.x · Cited by 24
Auletta, J. J., DeVecchio, J., Ferrara, J. L. M., & Heinzel, F. P. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.08.003 · Cited by 22 · cited 11×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluentialQian, B. F., Hammarström, M., & Danielsson, A. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00703.x · Cited by 13 · cited 8×
“These actions were mimicked by forskolin, absent in IELs from Glp1r mice, and attenuated by the GLP-1R agonist exendin (9-39) consistent with a GLP-1R–dependent mechanism of action.”
BackgroundMethodInfluential
Cited by
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
“The localization of GLP-1R expression to intestinal IELS within the immune system (Yusta et al., 2015) does not link direct activation of the immune GLP-1R to reduction of vascular or cardiac inflammation.”
BackgroundInfluentialSelf-citationCOVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
The Cardiovascular Biology of Glucagon-like Peptide-1
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665
Self-citation
Metadata
- Authors
- Yusta, B., Baggio, L. L., Koehler, J., Holland, D., Cao, X., Pinnell, L. J., Johnson-Henry, K. C., Yeung, W., Surette, M. G., Bang, K. W. A., Sherman, P. M., & Drucker, D. J.
- Affiliations
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- Cell Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
- McMaster University (CA)
- Corresponding author
- Drucker, Daniel J.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-03-03
- Volume
- 64
- Issue
- 7
- Pages
- 2537-2549
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1903699177
- Cited by
- 282
- References
- 56
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 34 · 2023: 20 · 2022: 32 · 2021: 29 · 2020: 20 · 2019: 29 · 2018: 16 · 2017: 18 · 2016: 7 · 2015: 6
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Inc
- Canadian Institutes of Health Research (MOP 123391, Novo Nordisk Inc)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- GLP-1 receptor agonists, exendin-4, exendin-9-39, intestinal intraepithelial lymphocytes, mucosal immunity, innate immunity, cAMP signaling, gut microbiota, intestinal injury, dextran sodium sulfate, bone marrow transplantation, obesity, cytokine and chemokine expression, epithelial barrier integrity
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, Female, Immunity, Innate, Intestinal Mucosa, Lymphocytes, Male, Mice, Inbred C57BL, Peptides, Venoms, Signal Transduction, Cytokines, Receptors, Glucagon, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.